CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
To confirm the safety and performance of the da Vinci SP Surgical System, Instruments and Accessories in a complex colorectal procedure such as low a...
Orlando, Florida, United States and 8 other locations
oral LOXO-292 in pediatric participants with an activating rearranged during transfection (RET) alteration and an advanced solid or primary CNS tumor...
Phase 1, Phase 2
Orlando, Florida, United States and 25 other locations
This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor...
Phase 2, Phase 3
Orlando, Florida, United States and 878 other locations
A Phase 1 dose escalation study in patients with advanced solid tumors harboring KRAS or EGFR mutations to determine the maximum tolerated d...
Phase 1
Orlando, Florida, United States and 11 other locations
evaluate the safety, tolerability, drug levels, molecular effects, and clinical activity of MRTX849 (adagrasib) in patients with advanced solid tumors...
Phase 1, Phase 2
Orlando, Florida, United States and 219 other locations
Study CA239-0006 is an open-label, randomized Phase 3 clinical trial comparing the efficacy of MRTX849 administered in combination with cetuximab ver...
Phase 3
Orlando, Florida, United States and 282 other locations
with standard chemotherapy for the potential treatment of colorectal cancer that:* has spread to other parts of the body (metastatic);* has ...
Phase 3
Orlando, Florida, United States and 410 other locations
versus a fluoropyrimidine/bevacizumab alone as assessed by molecular response which is based on changes in circulating tumor (ct)DNA. The...
Phase 2, Phase 3
Orlando, Florida, United States and 42 other locations
treatment) or* are metastatic (has spread to other parts of the body).This includes (but limited to) the following cancer types:* Non-Small...
Phase 1
Orlando, Florida, United States and 5 other locations
safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of KIN-2787 in adults with BRAF/NRAS-mutated advanced or metastatic solid tumors...
Phase 1
Orlando, Florida, United States and 43 other locations
Clinical trials
Research sites
Resources
Legal